Medical News Today
- Advertisement -
- Poison control centers across the United States are witnessing a concerning increase in inquiries related to semaglutide, an injectable medication used for diabetes management and weight loss.
- Reports of inadvertent overdoses have led to hospitalizations in some cases, with symptoms including intense nausea, vomiting and abdominal discomfort.
- Data from America’s Poison Centers reveals a startling 15-fold increase in semaglutide-related calls between January and November, primarily attributed to dosage errors, amid concerns over the safety of compounded formulations of the drug.
Semaglutide, a glucagon-like peptide-1 receptor agonist or GLP-1 analog, gained approval from the Food and Drug Administration (FDA) in 2017.
The medicine is marketed as Ozempic for diabetes management and Wegovy for weight loss.
Folllow the link below to Medical News Today to read the full story:
- Advertisement -
https://www.medicalnewstoday.com/articles/what-happens-if-you-take-too-much-ozempic-or-wegovy
Information source: https://www.medicalnewstoday.com
- Advertisement -
